Abstract
Safety and Efficacy of Switching Patients With Type 2 Diabetes From Glucagon-Like Peptide-1 Receptor Agonists to Tirzepatide: A Case Series
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have